| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.085 | 0.09 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.028 | 0.6 |